Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Stroke. 2015 Nov 24;47(1):214–220. doi: 10.1161/STROKEAHA.115.011046

Fig. 4.

Fig. 4

D-4F-treatment increased PCN neurite/axonal outgrowth and IGF1 mediated D-4F-treatment induced neurite/axonal outgrowth; D-4F-treatment did not increase OPC proliferation but decrease OPC death after stroke. Neurite-outgrowth (A), axonal-outgrowth (B), OPC MTS and LDH (C) assays and quantitative data.